Kymera Therapeutic
$37.509876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$37.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$2.49 (+7.11%) Today
$0.00 (0.00%) As of 6:00 PM EDT after-hours
Why Robinhood?
You can buy or sell KYMR and other stocks, options, and ETFs commission-free!
About KYMR
Kymera Therapeutics, Inc. operates as a biotechnology company, which engages in curing untreatable diseases. It focuses on discovering and developing novel small molecule therapeutics. Read More The firm's proprietary integrated degradation platform consists of informatics-driven target identification, novel E3 ligases and ligands, proprietary predictive modeling, and novel degradation tools. The company was founded by Bruce Lee Booth and Nello Mainolfi in September 2015 and is headquartered in Watertown, MA. The listed name for KYMR is Kymera Therapeutics, Inc. Common Stock.
Employees
54
Headquarters
Watertown, Massachusetts
Founded
2015
Market Cap
1.67B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
89.25K
High Today
$39.99
Low Today
$35.13
Open Price
$35.13
Volume
57.55K
52 Week High
$41.71
52 Week Low
$25.43